- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: lithium als.
Displaying page 1 of 1.
EudraCT Number: 2008-006891-31 | Sponsor Protocol Number: RAA/2008/013 | Start Date*: 2009-02-17 | |||||||||||
Sponsor Name:King's College London | |||||||||||||
Full Title: A randomised placebo-controlled trial of Lithium carbonate in Amyotrophic Lateral Sclerosis (LiCALS) | |||||||||||||
Medical condition: Amyotrophic Lateral Sclerosis (ALS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000579-19 | Sponsor Protocol Number: MAGNET | Start Date*: 2021-06-25 |
Sponsor Name:Stichting TRICALS Foundation | ||
Full Title: A Multi-arm, Adaptive, Group-sequential trial NETwork to evaluate drug efficacy in patients with Amyotrophic Lateral Sclerosis (ALS) | ||
Medical condition: Amyotrophic Lateral Sclerosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-002110-22 | Sponsor Protocol Number: LTA-2-2008 | Start Date*: 2008-09-16 | |||||||||||
Sponsor Name:Prof. dr L.H. van den Berg, UMC-Utrecht | |||||||||||||
Full Title: A randomised sequential trial of Lithium in amyotrophic lateral sclerosis | |||||||||||||
Medical condition: Amyotrophic lateral sclerosis (ALS) is a disease characterised by progressive degeneration of motor neurons in brain and spinal cord leading to muscle weakness. ALS can occur at anytime in adulthoo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010060-41 | Sponsor Protocol Number: 2707/2009 | Start Date*: 2009-02-24 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Evaluation of efficacy of lithium salts therapy in patients with Amyotrophic Lateral Sclerosis. | |||||||||||||
Medical condition: Amyotrophic Lateral Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002379-16 | Sponsor Protocol Number: 2007-002379-16 | Start Date*: 2007-05-29 | |||||||||||
Sponsor Name:I.N.M. NEUROMED (I.R.C.C.S.) S.R.L. GIA' SANATRIX | |||||||||||||
Full Title: MULTICENTER TRIAL (SINGLE BLIND)VS ON THE EFFICACY OF LITHIUM SALTS +RILUZOLE VS PLACEBO+RILUZOLE IN PATIENTS AFFECTED BY AMYOTROPHIC LATERAL SCLEROSIS | |||||||||||||
Medical condition: Patients affected by amyotrophic lateral sclerosis (ALS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006722-34 | Sponsor Protocol Number: SLA_Litio | Start Date*: 2009-06-23 | |||||||||||
Sponsor Name:ISTITUTO SUPERIORE DI SANITA` | |||||||||||||
Full Title: Multicentric randomized placebo controlled trial of Lithium carbonate combined with Riluzole in patients with ALS | |||||||||||||
Medical condition: Amyotrophic Lateral Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001094-15 | Sponsor Protocol Number: LitALS | Start Date*: 2008-03-10 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: SINGLE-BLIND, RANDOMIZED, PARALLEL GROUP, DOSE-FINDING TRIAL ON LITHIUM FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) | |||||||||||||
Medical condition: ALS patient according with the El-Escorial criteria | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003707-32 | Sponsor Protocol Number: P080401 | Start Date*: 2008-10-09 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Etude de l'effet du carbonate de lithium sur une population de patients atteints de SLA en ouvert en comparaison avec une population de référence. LISLA | |||||||||||||
Medical condition: Patient atteint de sclérose latérale amyotrophique. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006224-61 | Sponsor Protocol Number: EC08/00077 | Start Date*: 2009-06-12 | |||||||||||
Sponsor Name:Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |||||||||||||
Full Title: Ensayo clínico multicéntrico, aleatorizado, controlado para evaluar la eficacia del tratamiento con carbonato de litio en pacientes con Esclerosis Lateral Amiotrófica | |||||||||||||
Medical condition: Esclerosis Lateral Amiotrófica | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005106-38 | Sponsor Protocol Number: ec01/08liela | Start Date*: 2009-05-14 | |||||||||||
Sponsor Name:Lucia Galan Hospital Clinico San Carlos | |||||||||||||
Full Title: ENSAYO CLÍNICO RANDOMIZADO DOBLE CIEGO DE CARBONATO DE LITIO COMO TERAPIA DE ASOCIACIÓN EN ESCLEROSIS LATERAL AMIOTRÓFICA (FASE II) | |||||||||||||
Medical condition: Esclerosis Lateral Amiotrofica | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004547-35 | Sponsor Protocol Number: IMP27330.1 | Start Date*: 2007-01-10 | |||||||||||
Sponsor Name:Serono GmbH | |||||||||||||
Full Title: Phase IV study to investigate neutrophil downregulation of Thy-1 by Raptiva® (Efalizumab) as a potential responder predictor in patients with moderate to severe plaque psoriasis | |||||||||||||
Medical condition: Moderate to severe chronic plaque psoriasis (PASI ≥ 12) failing to respond to, or with a contraindication to, or intolerant to other systemic therapies including cyclosporine, methotrexate and Psor... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.